Reducing insulin dose and/or stopping it would be expected to reduce insulin-induced weight gain, hypoglycemia risk (online supplementary table S7) and the negative impact on QoL.9 Furthermore, there was a significant reduction in SU usage in the intervention group at 12 months, which was a result of medication reduction to prevent hypoglycemic episodes. Here, INS is linked to Hypoglycemia.